Profile
Conley Chee worked as the Head-Global Portfolio Management at Novartis Pharmaceuticals from 2018 to 2021.
He then served as the Chief Business & Commercial Officer at Syros Pharmaceuticals, Inc. from 2021 to 2023.
Mr. Chee completed his undergraduate studies at the University of Alberta and obtained an MBA from the Richard Ivey School of Business.
Former positions of Conley Chee
| Companies | Position | End |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Chief Executive Officer | 2024-11-21 |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2021-02-27 |
Training of Conley Chee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Richard Ivey School of Business
Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Conley Chee
















